UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

British journal of cancer, 2013-05, Vol.108 (10), p.2045-2055

2013

Volltextzugriff (PDF)

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Investigational new drugs, 2009-08, Vol.27 (4), p.379-386

2009

Volltextzugriff (PDF)

Cloning the Interleukin 1 Receptor from Human T Cells

Proceedings of the National Academy of Sciences - PNAS, 1989-11, Vol.86 (22), p.8946-8950

1989

Volltextzugriff (PDF)

A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma

Cancer gene therapy, 2003-04, Vol.10 (4), p.251-259

2003

Volltextzugriff (PDF)

Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice

Gene therapy, 2000-09, Vol.7 (17), p.1447-1457

2000

Volltextzugriff (PDF)

Gene-Based Vaccines and Immunotherapeutics

Proceedings of the National Academy of Sciences - PNAS, 2004-10, Vol.101 (Suppl 2), p.14567-14571

2004

Volltextzugriff (PDF)

Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen

The Journal of biological chemistry, 1986-12, Vol.261 (34), p.16210-16214

1986

Volltextzugriff (PDF)

MUC1 as a target antigen for cancer immunotherapy

Expert review of vaccines, 2005-08, Vol.4 (4), p.493-502

2005

Volltextzugriff (PDF)

Differential MUC 1 expression in normal and neoplastic human pancreatic tissue : An immunohistochemical study of 60 samples

American journal of clinical pathology, 1999-11, Vol.112 (5), p.635-640

1999

Volltextzugriff (PDF)

Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas

Blood, 2004-09, Vol.104 (6), p.1631-1638

2004

Volltextzugriff (PDF)

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

The journal of gene medicine, 2003-08, Vol.5 (8), p.690-699

2003

Volltextzugriff (PDF)

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment

Human gene therapy, 2000-07, Vol.11 (10), p.1417-1428

2000

Volltextzugriff (PDF)

Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L

Cancer gene therapy, 2005-02, Vol.12 (2), p.198-205

2005

Volltextzugriff (PDF)

Evaluating the Impact of AB 705 on Remediation: A Teacher’s Perspective

Acres, Dustin B

2021

Volltextzugriff (PDF)

Lack of evidence for an immunosuppressive role for MUC1

Cancer Immunology, Immunotherapy, 1999-04, Vol.48 (1), p.22-28

1999

Volltextzugriff (PDF)

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer

Cancer Immunology, Immunotherapy, 2002-12, Vol.51 (11-12), p.645-654

2002

Volltextzugriff (PDF)

Biomarkers associated with clinical outcome in advanced non-small cell lung cancer patients treated with TG4010

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.3027-3027

2009

Volltextzugriff (PDF)

Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells

The Journal of immunology (1950), 1987-10, Vol.139 (7), p.2268-2274

1987

Volltextzugriff (PDF)

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

Journal of immunotherapy, 2000-09, Vol.23 (5), p.570-580

2000

Volltextzugriff (PDF)

Randomized phase IIb trial evaluating the therapeutic vaccine TG4010 (MVA-MUC1-IL2) as an adjunct to chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8023-8023

2008

Volltextzugriff (PDF)

A method for identifying soil catenas and determining map unit composition used in a reconnaissance soil survey in Tanzania

Geoderma, 1993-06, Vol.57 (4), p.387-404

1993

Volltextzugriff (PDF)

Secretomers as a new tool for the monitoring of CTL responses

Cancer Immunology, Immunotherapy, 2005-06, Vol.54 (6), p.548-556

2005

Volltextzugriff (PDF)

Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (20), p.9536-9546

2005

Volltextzugriff (PDF)

Effects of platelet-derived growth factor and epidermal growth factor on antigen-induced proliferation of human T-cell lines

Immunology, 1985, Vol.54 (1), p.9-16

1985

Volltextzugriff (PDF)

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Cancer Immunology, Immunotherapy, 2000, Vol.48 (10), p.588-594

2000

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(3)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(57)
Humans
(47)
Animals
(34)
Biological And Medical Sciences
(29)
Mice
(29)
Female
(27)
Immunology
(22)
Immunotherapy
(21)
Oncology
(21)
Medical Sciences
(17)
T-Lymphocytes - Immunology
(16)
Medicine, Research & Experimental
(15)
Research & Experimental Medicine
(15)
Male
(14)
Lymphocyte Activation
(13)
Lymphocytes T
(13)
Biotechnology & Applied Microbiology
(12)
Fundamental And Applied Biological Sciences. Psychology
(12)
Immunotherapy - Methods
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Cloning the Interleukin 1 Receptor from Human T Cells

A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma

Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice

Gene-Based Vaccines and Immunotherapeutics

Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen

MUC1 as a target antigen for cancer immunotherapy

Differential MUC 1 expression in normal and neoplastic human pancreatic tissue : An immunohistochemical study of 60 samples

Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment

Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L

Evaluating the Impact of AB 705 on Remediation: A Teacher’s Perspective

Lack of evidence for an immunosuppressive role for MUC1

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer

Biomarkers associated with clinical outcome in advanced non-small cell lung cancer patients treated with TG4010

Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

Randomized phase IIb trial evaluating the therapeutic vaccine TG4010 (MVA-MUC1-IL2) as an adjunct to chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)

A method for identifying soil catenas and determining map unit composition used in a reconnaissance soil survey in Tanzania

Secretomers as a new tool for the monitoring of CTL responses

Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity

Effects of platelet-derived growth factor and epidermal growth factor on antigen-induced proliferation of human T-cell lines

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Suchergebnisse filtern